Header Logo

Connection

Sue Leurgans to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Sue Leurgans has written about Drug Administration Schedule.
Sue Leurgans
Connection Strength
0.076
Drug Administration Schedule
  1. Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013; 8(5):e64111.
    View in: PubMed
    Score: 0.028
  2. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92.
    View in: PubMed
    Score: 0.021
  3. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
    View in: PubMed
    Score: 0.016
  4. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.